More on MKKGY
Data
News
|
|||||
|---|---|---|---|---|---|
| Prev. Close | $26.49 |
|
|||
| Open | $25.49 | ||||
| 52 Wk High | $ | ||||
| 52 Wk Low | $ | ||||
| Day High | $25.76 | ||||
| Day Low | $25.37 | ||||
| P/E | N/A | ||||
| EPS | $ | ||||
| Volume | 174,695 | ||||
- EMD Serono Advances Patient Access to IVF Medicines in the U.S., Aligned with National Health Priorities
- FDA Accepts New Drug Application for Pimicotinib for the Treatment of Tenosynovial Giant Cell Tumor
- EMD Serono Takes Patient-Directed Approach to Bring Innovation to the Treatment of Rare Neuromuscular Disorder, Generalized Myasthenia Gravis
- MilliporeSigma Partners with Promega to Advance 3-D Cell Drug Discovery Technologies
- Pimicotinib Treatment Demonstrates Deep and Durable Tumor Responses and Continued Improvements in Pain and Function for Patients with TGCT
- EMD Serono agrees with U.S. to cut IVF drug prices by 84%
- EMD Serono Announces Unprecedented Agreement with U.S. Government to Expand Access to IVF Therapies
- MilliporeSigma to acquire JSR Life Sciences chromatography business
- MilliporeSigma to Acquire Chromatography Business of JSR Life Sciences, Expanding Protein A Capabilities and Downstream Portfolio
- EMD Serono to Present New Data Highlighting Durable Effects of MAVENCLAD® in Relapsing Multiple Sclerosis (RMS) at ECTRIMS 2025
Entities mentioned with MKKGY
- FDA | View Related Stories »
- Twitter | View Related Stories »
- Definitive Agreement | View Related Stories »
- Deutsche Bank | View Related Stories »
- Hedge Funds | View Related Stories »
- Earnings | View Related Stories »
- Dividend | View Related Stories »
- Bernard Madoff | View Related Stories »
- Show More...
